The effect of N-acetylcysteine (NAC) on human cognition – A systematic review
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
HighlightsOxidation and neuroinflammation modulate cognition through a variety of vectors.NAC mitigates the cognitive effects of neuroinflammation in animals.Evidence that NAC can modulate human cognition is promising but inconsistent.Combined antioxidants are effective, but the specific contribution of NAC is unknown.Further exploration of NAC’s ability to modify cognitive change is warranted. Abstract Oxidative stress, neuroinflammation and neurogenesis are commonly implicated as cognitive modulators across a range of disorders. N‐acetylcysteine (NAC) is a glutathione precursor with potent antioxidant, pro‐neurogenesis and anti‐inflammatory properties and a favourable safety profile. A systematic review of the literature specifically examining the effect of NAC administration on human cognition revealed twelve suitable articles for inclusion: four examining Alzheimer's disease; three examining healthy participants; two examining physical trauma; one examining bipolar disorder, one examining schizophrenia, and one examining ketamine‐induced psychosis. Heterogeneity of studies, insufficiently powered studies, infrequency of cognition as a primary outcome, heterogeneous methodologies, formulations, co‐administered treatments, administration regimes, and assessment confounded the drawing of firm conclusions. The available data suggested statistically significant cognitive improvements following NAC treatment, though the paucity of NAC‐specific research makes it difficult to determine if this effect is meaningful. While NAC may have a positive cognitive effect in a variety of contexts; larger, targeted studies are warranted, specifically evaluating its role in other clinical disorders with cognitive sequelae resulting from oxidative stress and neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
Self-citationBerk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
Self-citationBlood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke
Khatri, R., McKinney, A. M., Swenson, B., & Janardhan, V. (2012) · Neurology · doi:10.1212/wnl.0b013e3182697e70 · Cited by 478 · cited 2×
“…induced by trauma has been shown to share inflammatory sequelae in the BBB with long-term neurological disorders such as Alzheimer's disease (Erickson et al., 2012); epilepsy (Liu et al., 2012); stroke (Khatri et al., 2012); and multiple sclerosis (Lund et al., 2013); among other conditions.”
Polyunsaturated Fatty Acids, Antioxidants, and Cognitive Function in Very Old Men
Kalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009029 · Cited by 453 · cited 1×
“…et al., 2014; Gray et al., 2008; Gray et al., 2003; Grodstein et al., 2003; Guidi et al., 2006; Iuliano et al., 2010; Jama et al., 1996; Kalmijn et al., 1997; Kesse-Guyot et al., 2011; Klugman et al., 2012; La Rue et al., 1997; Lott et al., 2011; Maxwell et al., 2005; McNeill et al.,…”
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434 · cited 5×
“Glutathione assists in maintaining oxidative homeostasis by removing reactive oxygen species, reactive nitrogen species, and peroxides (Samuni et al., 2013; Berk et al., 2013).”
InfluentialSelf-citationPadurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378 · cited 1×
“…et al., 2011; Klugman et al., 2012; La Rue et al., 1997; Lott et al., 2011; Maxwell et al., 2005; McNeill et al., 2007; Mendelsohn et al., 1998; Padurariu et al., 2010; Paganini-Hill and Clark, 2007; Pecina et al., 2014; Reinecke et al., 2010; Savenkov et al., 2013; Smith and Fein, 2010;…”
Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., Cotman, C., Cottrell, B., Montine, T. J., Thomas, R. G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.85 · Cited by 377
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · cited 4×
“For example, cognitive dysfunction in Alzheimer's disease has been characterized by increased levels of amyloid and tau proteins in the brain (Cai et al., 2011; Sinha et al., 2015), and NAC has demonstrated efficacy to mitigate this in animal models (Hsiao et al., 2012; Sinha et al., 2015) though…”
InfluentialJama, J. W., Launer, L. J., Witteman, J. C. M., den Breeijen, J. H., Breteler, M. M. B., Grobbee, D. E., & Hofman, A. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008922 · Cited by 252
Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease
Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240
Barrientos, R. M., Hein, A. M., Frank, M. G., Watkins, L. R., & Maier, S. F. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2173-12.2012 · Cited by 235 · cited 2×
“…by strong indications within the pre-clinical literature that trauma can facilitate the production of reactive oxygen species associated with neuroinflammation and is associated with cognitive decline (Barrientos et al., 2012; Cibelli et al., 2010; Rosczyk et al., 2008; Vacas et al., 2013).”
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
Holmay, M. J., Terpstra, M., Coles, L. D., Mishra, U., Ahlskog, M., Öz, G., Cloyd, J. C., & Tuite, P. J. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31829ae713 · Cited by 216 · cited 1×
“Further, there is clinical evidence to suggest NAC may be neuroprotective based on imaging data (Amen et al., 2011a,b, 2013; Holmay et al., 2012; Levin et al., 2014).”
High-dose antioxidant supplements and cognitive function in community-dwelling elderly women
Grodstein, F., Chen, J., & Willett, W. C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.4.975 · Cited by 214 · cited 1×
“…et al., 2012; Gassio et al., 2008; Giavarotti et al., 2013; Golub et al., 2011; Gonzalez-Reimers et al., 2014; Gray et al., 2008; Gray et al., 2003; Grodstein et al., 2003; Guidi et al., 2006; Iuliano et al., 2010; Jama et al., 1996; Kalmijn et al., 1997; Kesse-Guyot et al., 2011; Klugman et al.,…”
Hoffer, M. E., Balaban, C., Slade, M. D., Tsao, J. W., & Hoffer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054163 · Cited by 207 · cited 6×
“Two studies examined the efficacy of NAC as an adjunct treatment for cognitive dysfunction believed to result from physical trauma (Amen et al., 2011a,b; n = 30, and Hoffer et al., 2013; n= 81).”
InfluentialOxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease
GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.001 · Cited by 203
Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation
Lott, I. T., Doran, E., Nguyen, V. Q., Tournay, A., Head, E., & Gillen, D. L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34114 · Cited by 136 · cited 1×
“…et al., 2006; Iuliano et al., 2010; Jama et al., 1996; Kalmijn et al., 1997; Kesse-Guyot et al., 2011; Klugman et al., 2012; La Rue et al., 1997; Lott et al., 2011; Maxwell et al., 2005; McNeill et al., 2007; Mendelsohn et al., 1998; Padurariu et al., 2010; Paganini-Hill and Clark, 2007; Pecina…”
Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults
Gray, S. L., Anderson, M. L., Crane, P. K., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., & Larson, E. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01531.x · Cited by 127
Supplemental Use of Antioxidant Vitamins and Subsequent Risk of Cognitive Decline and Dementia
Maxwell, C. J., Hicks, M. S., Hogan, D. B., Basran, J., & Ebly, E. M. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000085074 · Cited by 105 · cited 1×
“…et al., 2010; Jama et al., 1996; Kalmijn et al., 1997; Kesse-Guyot et al., 2011; Klugman et al., 2012; La Rue et al., 1997; Lott et al., 2011; Maxwell et al., 2005; McNeill et al., 2007; Mendelsohn et al., 1998; Padurariu et al., 2010; Paganini-Hill and Clark, 2007; Pecina et al., 2014;…”
Alabdali, A., Al-Ayadhi, L., & El-Ansary, A. (2014) · Behavioral and Brain Functions · doi:10.1186/1744-9081-10-14 · Cited by 101 · cited 1×
“…years Excluded articles after full-text review: No cognitive outcome directly measured/only global functioning assessed: (Abu Hashim et al., 2010; Alabdali et al., 2014; Alboni et al., 2013; Barkholt et al., 2008; Berk et al., 2008b, 2012; Carmeli et al., 2012; Cereser et al., 2001; Cervellati…”
Otte, D.-M., Sommersberg, B., Kudin, A., Guerrero, C., Albayram, Ö., Filiou, M. D., Frisch, P., Yilmaz, Ö., Drews, E., Turck, C. W., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.109 · Cited by 97
Glutamatergic Modulation of Auditory Information Processing in the Human Brain
Gunduz-Bruce, H., Reinhart, R. M. G., Roach, B. J., Gueorguieva, R., Oliver, S., D'Souza, D. C., Ford, J. M., Krystal, J. H., & Mathalon, D. H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.031 · Cited by 93
Haxaire, C., Turpin, F. R., Potier, B., Kervern, M., Sinet, P., Barbanel, G., Mothet, J., Dutar, P., & Billard, J. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00792.x · Cited by 88
Mendelsohn, A. B., Belle, S. H., Stoehr, G. P., & Ganguli, M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009556 · Cited by 88 · cited 1×
“…et al., 1997; Kesse-Guyot et al., 2011; Klugman et al., 2012; La Rue et al., 1997; Lott et al., 2011; Maxwell et al., 2005; McNeill et al., 2007; Mendelsohn et al., 1998; Padurariu et al., 2010; Paganini-Hill and Clark, 2007; Pecina et al., 2014; Reinecke et al., 2010; Savenkov et al., 2013;…”
Parachikova, A., Green, K. N., Hendrix, C., & LaFerla, F. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014015 · Cited by 87 · cited 2×
“…levels of the amyloidogenic proteins implicated, which can be ameliorated by NAC administration, and this improvement may be mediated by decreases in the toxic forms of these proteins (Hsiao et al., 2012; Parachikova et al., 2010) as well as by modulation of oxidative stress (Huang et al., 2010).”
Acetyl-l-carnitine for dementia
Hudson, S. A., & Tabet, N. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003158 · Cited by 86
Carmeli, C., Knyazeva, M. G., Cuénod, M., & Do, K. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029341 · Cited by 81
Is antioxidant use protective of cognitive function in the community-dwelling elderly?
Gray, S. L., Hanlon, J. T., Landerman, L. R., Artz, M., Schmader, K. E., & Fillenbaum, G. G. (2003) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(03)80011-9 · Cited by 70
Effects of N‐acetyl cysteine on cognitive function in bipolar disorder
Dean, O. M., Bush, A. I., Copolov, D. L., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02392.x · Cited by 58
Self-citationA preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania
Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58 · cited 1×
“…2013; Grant et al., 2007; Karbasi et al., 2013; Kerksick et al., 2013; Khan et al., 2005; Lee et al., 2010; Lin et al., 2010; Lindblad et al., 2011; Magalhaes et al., 2011, 2012, 2013; Mantovani et al., 2003; Nasr, 2010; Oner and Muderris, 2011; Ozaydin et al., 2013; Parr and Huitson, 1987; Rasi…”
Self-citationTotal antioxidant capacity of diet in relation to cognitive function and decline
Devore, E. E., Kang, J. H., Stampfer, M. J., & Grodstein, F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29634 · Cited by 55
Verbal Fluency Predicts Mortality in Alzheimer Disease
Cosentino, S., Scarmeas, N., Albert, S. M., & Stern, Y. (2006) · Cognitive and Behavioral Neurology · doi:10.1097/01.wnn.0000213912.87642.3d · Cited by 54 · cited 1×
“Given that reduced verbal fluency in the early stages has been shown to be one of the few neuropsychological measures predictive of mortality in AD (Cosentino et al., 2006) findings of improvement on this test, in this population is particularly intriguing.”
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons
Alboni, S., Gibellini, L., Montanari, C., Benatti, C., Benatti, S., Tascedda, F., Brunello, N., Cossarizza, A., & Pariante, C. M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000266 · Cited by 35
Cited by
Safavynia, S. A., & Goldstein, P. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00752 · Cited by 339
Skvarc, D. R., Berk, M., Byrne, L. K., Dean, O. M., Dodd, S., Lewis, M., Marriott, A., Moore, E. M., Morris, G., Page, R. S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.011 · Cited by 312
Self-citationRaghu, G., Berk, M., Campochiaro, P. A., Jaeschke, H., Marenzi, G., Richeldi, L., Wen, F.-Q., Nicoletti, F., & Calverley, P. M. A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666201230144109 · Cited by 280
Self-citationThe Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00907-3 · Cited by 87
Self-citationHaller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105120 · Cited by 13
“in cognition in the clinical literature (Skvarc et al., 2017), making it a promising candidate to”
Background
Metadata
- Authors
- Skvarc, D. R., Dean, O. M., Byrne, L. K., Gray, L., Lane, S., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 78
- Pages
- 44-56
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2606945698
- Cited by
- 111
- References
- 33
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.